Literature DB >> 22126573

Esophageal cancer mortality trends during the last 30 years in high risk areas in China: comparison of results from national death surveys conducted in the 1970's, 1990's and 2004-2005.

Wen-Qiang Wei1, Juan Yang, Si-Wei Zhang, Wan-Qing Chen, You-Lin Qiao.   

Abstract

BACKGROUND AND AIMS: China was one of the countries with the highest esophagus cancer (EC) mortality in the world during the 1970's. This report provides data on time trends of esophagus cancer mortality during the 1970's-21st century in high risk areas, considering the remarkable geographic variation of EC mortality in China. The aim was to explore changing trends of EC mortality during past 30 years, and provide basic information on prevention and control of EC in high risk areas in China.
METHODS: Among the high risk areas of EC defined in the 1970's, ten that have joined in all the three death causes sampling surveys were selected in this study. Subjects included all cases dying from esophageal cancer in these sites during 1973-1975, 1990-1992, and 2004-2005. The EC mortality data and relevant demographic data of ten areas covered by all the three surveys were extracted from the national death causes survey database.
RESULTS: Compared with the EC mortality of the ten high risk areas in the 1970's, the crude mortality rates (CMR) in the 1990's reduced by 0.04%~47.3%, and the CMRs in the early 21st century decreased by 9.25%~62.0% from the 1990's; the age specific mortality rate adjusted by China standard population (ASMRc) in the 1990's reduced by 8.22%~53.5%, and the ASWRc in the early 21st century decreased by 25.0%~78.0% from the 1990's; the age-specific mortality rates adjusted by world standard population (ASMRw) in the 1990's reduced by 7.54%~51.9%, and the ASMRw in the early 21st century decreased by 24.5%~79.2% from the 1990's; the proportional mortality ratios (PMR) in the 1990's reduced by 12.3%~41.3%, and the PMRs in the early 21st century decreased by 6.76%~52.6% from the 1990's.
CONCLUSION: Our study indicated that the mortality of esophageal cancer in high risk areas of China had declined after three decades, but still remained high compared with the national level. Esophageal cancer is still a major cancer burden in high risk areas. It is necessary to further promote the prevention and control program of esophageal cancer in these areas of China.

Entities:  

Mesh:

Year:  2011        PMID: 22126573

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.

Authors:  Bo Chen; Lei Cao; Kong-Wang Hu; Jia-Wei Zhang; Xiang-Ling Meng; Mao-Ming Xiong
Journal:  Tumour Biol       Date:  2013-12-13

2.  Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.

Authors:  Yong-Cheng Ma; Nan Su; Xiao-Jing Shi; Wen Zhao; Yu Ke; Xiaolin Zi; Ning-Min Zhao; Yu-Hua Qin; Hong-Wei Zhao; Hong-Min Liu
Journal:  Toxicol Appl Pharmacol       Date:  2014-11-20       Impact factor: 4.219

3.  Esophageal cancer incidence and mortality in China, 2009.

Authors:  Wanqing Chen; Yutong He; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

4.  The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China.

Authors:  Hao Feng; Guohui Song; Shanrui Ma; Qing Ma; Xinqing Li; Wenqiang Wei; Christian Abnet; Youlin Qiao; Guoqing Wang
Journal:  J Gastroenterol Hepatol       Date:  2020-05-24       Impact factor: 4.369

Review 5.  Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis.

Authors:  J L Petrick; A B Wyss; A M Butler; C Cummings; X Sun; C Poole; J S Smith; A F Olshan
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

6.  Metallic expandable stents in the management of malignant tracheal stenosis due to esophageal cancer with lymph node metastasis.

Authors:  Zhaohong Peng; Shengde Xu; Hua Li; Chaobin Sun; Minyan Fu
Journal:  Oncol Lett       Date:  2013-09-17       Impact factor: 2.967

7.  Analysis of salivary microRNA expression profiles and identification of novel biomarkers in esophageal cancer.

Authors:  Jiang Du; Lin Zhang
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

8.  Socioeconomic status is inversely associated with esophageal squamous cell carcinoma risk: results from a population-based case-control study in China.

Authors:  Peipei Gao; Xiaorong Yang; Chen Suo; Ziyu Yuan; Hongwei Cheng; Yuechan Zhang; Li Jin; Ming Lu; Xingdong Chen; Weimin Ye
Journal:  Oncotarget       Date:  2018-01-06

9.  Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.

Authors:  Hongjin Wu; Juehua Yu; Deshengyue Kong; Yu Xu; Zunyue Zhang; Jing Shui; Ziwei Li; Huayou Luo; Kunhua Wang
Journal:  Int J Oncol       Date:  2019-10-14       Impact factor: 5.650

10.  YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice.

Authors:  Nan Zhao; Yousheng Mao; Gaijing Han; Qiang Ju; Lanping Zhou; Fang Liu; Yang Xu; Xiaohang Zhao
Journal:  Oncotarget       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.